116 related articles for article (PubMed ID: 35931556)
1. Development and validation of the Massachusetts General Hospital/Memorial Sloan Kettering nomogram to predict overall survival of resected patients with pancreatic ductal adenocarcinoma treated with neoadjuvant therapy.
Qiao G; Ilagan CH; Fernandez-Del Castillo C; Ferrone CR; Janseen QP; Balachandran VP; Sell NM; Drebin JA; Hank T; Kingham TP; D'Angelica MI; Jarnagin WR; Lillemoe KD; Wei AC; Qadan M
Surgery; 2022 Oct; 172(4):1228-1235. PubMed ID: 35931556
[TBL] [Abstract][Full Text] [Related]
2. A nomogram based on preoperative inflammatory markers predicting the overall survival of pancreatic ductal adenocarcinoma.
Xu J; Shi KQ; Chen BC; Huang ZP; Lu FY; Zhou MT
J Gastroenterol Hepatol; 2017 Jul; 32(7):1394-1402. PubMed ID: 27973703
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of models to prognosticate survival after surgery for pancreatic cancer in the era of neoadjuvant therapy.
Marcinak CT; Parker WF; Parikh AA; Datta J; Maithel SK; Kooby DA; Burkard ME; Kim HJ; LeCompte MT; Afshar M; Churpek MM; Zafar SN
J Surg Oncol; 2023 Aug; 128(2):280-288. PubMed ID: 37073788
[TBL] [Abstract][Full Text] [Related]
4. Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival.
Ferrone CR; Kattan MW; Tomlinson JS; Thayer SP; Brennan MF; Warshaw AL
J Clin Oncol; 2005 Oct; 23(30):7529-35. PubMed ID: 16234519
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a prognostic model to predict the prognosis of patients who underwent chemotherapy and resection of pancreatic adenocarcinoma: a large international population-based cohort study.
Huang L; Balavarca Y; van der Geest L; Lemmens V; Van Eycken L; De Schutter H; Johannesen TB; Zadnik V; Primic-Žakelj M; Mägi M; Grützmann R; Besselink MG; Schrotz-King P; Brenner H; Jansen L
BMC Med; 2019 Mar; 17(1):66. PubMed ID: 30905320
[TBL] [Abstract][Full Text] [Related]
6. A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma.
Guo SW; Shen J; Gao JH; Shi XH; Gao SZ; Wang H; Li B; Yuan WL; Lin L; Jin G
Surgery; 2020 Dec; 168(6):1003-1014. PubMed ID: 32321665
[TBL] [Abstract][Full Text] [Related]
7. Validation of the Memorial Sloan Kettering Gastric Cancer Post-Resection Survival Nomogram: Does It Stand the Test of Time?
Nakauchi M; Court CM; Tang LH; Gönen M; Janjigian YY; Maron SB; Molena D; Coit DG; Brennan MF; Strong VE
J Am Coll Surg; 2022 Aug; 235(2):294-304. PubMed ID: 35839406
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of novel nomograms for predicting the survival of patients after surgical resection of pancreatic ductal adenocarcinoma.
Li G; Chen JZ; Chen S; Lin SZ; Pan W; Meng ZW; Cai XR; Chen YL
Cancer Med; 2020 May; 9(10):3353-3370. PubMed ID: 32181599
[TBL] [Abstract][Full Text] [Related]
9. Validation of the memorial Sloan-Kettering Cancer Center nomogram to predict disease-specific survival after R0 resection in a Chinese gastric cancer population.
Chen D; Jiang B; Xing J; Liu M; Cui M; Liu Y; Wang Z; Chen L; Yang H; Zhang C; Yao Z; Zhang N; Ji J; Qu H; Su X
PLoS One; 2013; 8(10):e76041. PubMed ID: 24146811
[TBL] [Abstract][Full Text] [Related]
10. Local relapse after breast-conserving therapy for ductal carcinoma in situ: a European single-center experience and external validation of the Memorial Sloan-Kettering Cancer Center DCIS nomogram.
Sweldens C; Peeters S; van Limbergen E; Janssen H; Laenen A; Patil S; Van Zee KJ; Weltens C
Cancer J; 2014; 20(1):1-7. PubMed ID: 24445756
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Nomogram for patients undergoing radical Pancreaticoduodenectomy for adenocarcinoma of the pancreatic head.
Wu C; Hou SZ; Wu Z; Huang X; Wang Z; Tian B
BMC Cancer; 2021 May; 21(1):624. PubMed ID: 34044806
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection.
Tong J; Jiang W; Mao S; Wu S; Lu C
Front Oncol; 2022; 12():1040411. PubMed ID: 36479089
[TBL] [Abstract][Full Text] [Related]
13. Validation of a nomogram for predicting survival after resection for adenocarcinoma of the pancreas.
de Castro SM; Biere SS; Lagarde SM; Busch OR; van Gulik TM; Gouma DJ
Br J Surg; 2009 Apr; 96(4):417-23. PubMed ID: 19283741
[TBL] [Abstract][Full Text] [Related]
14. Radiomics nomogram for the preoperative prediction of lymph node metastasis in pancreatic ductal adenocarcinoma.
Bian Y; Guo S; Jiang H; Gao S; Shao C; Cao K; Fang X; Li J; Wang L; Ma C; Zheng J; Jin G; Lu J
Cancer Imaging; 2022 Jan; 22(1):4. PubMed ID: 34991733
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Nomogram for Resected Pancreatic Adenocarcinoma: A TRIPOD-Compliant Retrospective Long-Term Survival Analysis.
Xu D; Zhang K; Li M; Neoptolemos JP; Wu J; Gao W; Wu P; Cai B; Yin J; Shi G; Lu Z; Jiang K; Miao Y
World J Surg; 2020 Apr; 44(4):1260-1269. PubMed ID: 31900571
[TBL] [Abstract][Full Text] [Related]
16. A Prognostic Nomogram for Disease-Specific Survival in Patients with Pancreatic Ductal Adenocarcinoma of the Head of the Pancreas Following Pancreaticoduodenectomy.
Li HB; Zhou J; Zhao FQ
Med Sci Monit; 2018 Sep; 24():6313-6321. PubMed ID: 30198517
[TBL] [Abstract][Full Text] [Related]
17. External validation of three lymph node ratio-based nomograms predicting survival using an international cohort of patients with resected pancreatic head ductal adenocarcinoma.
Schneider M; Labgaa I; Vrochides D; Zerbi A; Nappo G; Perinel J; Adham M; van Roessel S; Besselink M; Mieog JSD; Groen JV; Demartines N; Schäfer M; Joliat GR
Eur J Surg Oncol; 2022 Sep; 48(9):2002-2007. PubMed ID: 35606276
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a novel nomogram for predicting the prognosis of patients with resected pancreatic adenocarcinoma.
Ren H; Wu CR; Aimaiti S; Wang CF
Oncol Lett; 2020 Jun; 19(6):4093-4105. PubMed ID: 32382348
[TBL] [Abstract][Full Text] [Related]
19. A prognostic nomogram for stage II/III rectal cancer patients treated with neoadjuvant chemoradiotherapy followed by surgical resection.
Lin Y
BMC Surg; 2022 Jul; 22(1):256. PubMed ID: 35787802
[TBL] [Abstract][Full Text] [Related]
20. Development and Assessment of a Clinical Calculator for Estimating the Likelihood of Recurrence and Survival Among Patients With Locally Advanced Rectal Cancer Treated With Chemotherapy, Radiotherapy, and Surgery.
Weiser MR; Chou JF; Keshinro A; Chapman WC; Bauer PS; Mutch MG; Parikh PJ; Cercek A; Saltz LB; Gollub MJ; Romesser PB; Crane CH; Shia J; Markowitz AJ; Garcia-Aguilar J; Gönen M;
JAMA Netw Open; 2021 Nov; 4(11):e2133457. PubMed ID: 34748003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
